Trimodality treatment of malignant pleural mesothelioma

BATIREL H. F., METİNTAŞ M., Caglar H. B., YILDIZELİ B., LAÇİN T., BOSTANCI K., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.3, sa.5, ss.499-504, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 3 Sayı: 5
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1097/jto.0b013e31816fca1b
  • Dergi Adı: JOURNAL OF THORACIC ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.499-504
  • Anahtar Kelimeler: malignant pleural mesothelioma, extrapleural pneumonectomy, high-dose hemithoracic irradiation, adjuvant chemotherapy, PHASE-II TRIAL, EXTRAPLEURAL PNEUMONECTOMY, HEMITHORACIC RADIATION, INDUCTION CHEMOTHERAPY, THERAPY, RADIOTHERAPY, RESECTION, PLEURECTOMY/DECORTICATION, PATTERNS, DISEASE
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Introduction: Multimodality treatment has achieved significant success in local control and treatment of early-stage malignant pleural mesothelioma patients. However, its favorable effect on survival is questionable.